Also, CFO Scott B. Ullem sold 80,700 shares of Edwards Lifesciences stock in a transaction dated Wednesday, May 10th.

Source: https://www.etfdailynews.com/2023/07/23/edwards-lifesciences-nyseew-price-target-raised-to-105-00/

Altshuler Shaham Ltd acquired a new stake in shares of Edwards Lifesciences during the second quarter worth about $31,000.

Source: https://www.etfdailynews.com/2023/09/05/insider-selling-edwards-lifesciences-co-nyseew-director-sells-29350-shares-of-stock/

Bogart Wealth LLC acquired a new stake in Edwards Lifesciences during the 3rd quarter valued at $25,000.

Source: https://www.americanbankingnews.com/2023/01/30/caprock-group-inc-purchases-new-shares-in-edwards-lifesciences-co-nyseew.html

Bogart Wealth LLC purchased a new position in Edwards Lifesciences in the 3rd quarter valued at about $25,000.

Source: https://www.etfdailynews.com/2023/04/18/edwards-lifesciences-nyseew-pt-raised-to-93-00/

Canaccord Genuity Group reduced their target price on Edwards Lifesciences from $78.00 to $73.00 and set a “hold” rating on the stock in a report on Monday, December 12th.

Source: https://www.etfdailynews.com/2023/04/09/pinnacle-associates-ltd-has-323000-stock-holdings-in-edwards-lifesciences-co-nyseew/

Edwards Lifesciences has had an impeccable record of steadily rising earnings for more than two decades.

Source: https://seekingalpha.com/article/4591296-where-will-edwards-lifesciences-stock-be-in-4-years?source=feed_all_articles

Edwards Lifesciences () last released its quarterly earnings data on Wednesday, July 26th.

Source: https://www.etfdailynews.com/2023/09/29/edwards-lifesciences-nyseew-upgraded-at-oppenheimer/

Edwards Lifesciences () last released its quarterly earnings results on Wednesday, July 26th.

Source: https://www.americanbankingnews.com/2023/07/29/bahl-gaynor-inc-sells-335-shares-of-edwards-lifesciences-co-nyseew.html

Edwards Lifesciences will hold an open day at its state-of-the-art facility in Limerick to allow potential new employees to gain a sense of what it is like to work for the company and if it is the job for them.

Source: https://www.limerickpost.ie/2023/06/15/edwards-lifesciences-to-hold-open-evening-for-limerick-jobseekers-next-week/

Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Edwards Lifesciences from $113.00 to $83.00 in a report on Friday, October 28th.

Source: https://www.etfdailynews.com/2023/02/01/edwards-lifesciences-nyseew-stock-rating-lowered-by-sanford-c-bernstein/

Moneta Group Investment Advisors LLC raised its stake in shares of Edwards Lifesciences by 104,971.3% in the 4th quarter.

Source: https://www.dailypolitical.com/2023/05/31/edwards-lifesciences-co-nyseew-sees-significant-growth-in-short-interest.html

Morgan Stanley reissued an “overweight” rating and issued a $102.00 price objective on shares of Edwards Lifesciences in a research report on Friday, July 14th.

Source: https://www.americanbankingnews.com/2023/10/05/daveen-chopra-sells-8500-shares-of-edwards-lifesciences-co-nyseew-stock-2.html

On average, research analysts forecast that Edwards Lifesciences Co. will post 2.55 earnings per share for the current fiscal year.

Source: https://www.dailypolitical.com/2023/10/01/edwards-lifesciences-co-nyseew-shares-purchased-by-exchange-traded-concepts-llc.html

Stonegate Investment Group LLC increased its stake in shares of Edwards Lifesciences by 22.3% in the 1st quarter.

Source: https://www.etfdailynews.com/2023/07/14/2491-shares-in-edwards-lifesciences-co-nyseew-purchased-by-northcrest-asset-manangement-llc/

Trifecta Capital Advisors LLC purchased a new position in Edwards Lifesciences during the fourth quarter valued at $28,000.

Source: https://www.americanbankingnews.com/2023/04/26/asset-management-one-co-ltd-cuts-stock-position-in-edwards-lifesciences-co-nyseew.html

Truvestments Capital LLC lifted its holdings in Edwards Lifesciences by 260.0% in the second quarter.

Source: https://www.americanbankingnews.com/2023/12/27/edwards-lifesciences-co-nyseew-shares-sold-by-ifp-advisors-inc.html

Wagner Wealth Management LLC bought a new position in Edwards Lifesciences in the second quarter worth $44,000.

Source: https://www.etfdailynews.com/2023/01/09/assenagon-asset-management-s-a-acquires-65114-shares-of-edwards-lifesciences-co-nyseew/